Clinical Trial Update: DIG-HIF-1 Pharmacodynamic Trial in Newly Diagnosed Operable Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 pharmacodynamic trial update in newly diagnosed operable breast cancer completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-01-31